Cheryl Pegus's most recent trade in Boston Scientific Corp. was a trade of 2,081 Deferred Stock Units done . Disclosure was reported to the exchange on May 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Boston Scientific Corp. | Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 5,288 | - | - | Deferred Stock Units | |
Boston Scientific Corp. | Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 605 | 5,893 | - | - | Deferred Stock Units | |
Concentra Group Holdings P... | Cheryl B. Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 6,496 | 6,496 | - | 0 | Common Stock | |
Concentra Group Holdings P... | Pegus Cheryl B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 6,496 | 12,992 | - | 0 | Common Stock | |
Boston Scientific Corp. | Cheryl Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 2,800 | 2,800 | - | - | Deferred Stock Units | |
Boston Scientific Corp. | Cheryl Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 407 | 3,207 | - | - | Deferred Stock Units | |
Phreesia Inc | Cheryl Pegus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 2,605 | 15,825 (0%) | 0% | 0 | Common Stock | |
Phreesia Inc | Cheryl Pegus | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.45 per share. | 24 May 2021 | 3,555 | 13,220 (0%) | 0% | 45.5 | 161,575 | Common Stock |